These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 30626528)
1. SWATH proteomic profiling of prostate cancer cells identifies NUSAP1 as a potential molecular target for Galiellalactone. Garrido-Rodríguez M; Ortea I; Calzado MA; Muñoz E; García V J Proteomics; 2019 Feb; 193():217-229. PubMed ID: 30626528 [TBL] [Abstract][Full Text] [Related]
2. Galiellalactone induces cell cycle arrest and apoptosis through the ATM/ATR pathway in prostate cancer cells. García V; Lara-Chica M; Cantarero I; Sterner O; Calzado MA; Muñoz E Oncotarget; 2016 Jan; 7(4):4490-506. PubMed ID: 26683224 [TBL] [Abstract][Full Text] [Related]
3. The STAT3 Inhibitor Galiellalactone Effectively Reduces Tumor Growth and Metastatic Spread in an Orthotopic Xenograft Mouse Model of Prostate Cancer. Canesin G; Evans-Axelsson S; Hellsten R; Sterner O; Krzyzanowska A; Andersson T; Bjartell A Eur Urol; 2016 Mar; 69(3):400-4. PubMed ID: 26144873 [TBL] [Abstract][Full Text] [Related]
4. Galiellalactone is a direct inhibitor of the transcription factor STAT3 in prostate cancer cells. Don-Doncow N; Escobar Z; Johansson M; Kjellström S; Garcia V; Munoz E; Sterner O; Bjartell A; Hellsten R J Biol Chem; 2014 Jun; 289(23):15969-78. PubMed ID: 24755219 [TBL] [Abstract][Full Text] [Related]
5. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3. Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422 [TBL] [Abstract][Full Text] [Related]
6. STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population. Canesin G; Maggio V; Palominos M; Stiehm A; Contreras HR; Castellón EA; Morote J; Paciucci R; Maitland NJ; Bjartell A; Hellsten R Sci Rep; 2020 Aug; 10(1):13958. PubMed ID: 32811873 [TBL] [Abstract][Full Text] [Related]
7. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells. Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920 [TBL] [Abstract][Full Text] [Related]
8. Developmentally regulated GTP-binding protein 2 levels in prostate cancer cell lines impact docetaxel-induced apoptosis. Kim SC; Lee WH; Kim SH; Abdulkhayevich AA; Park JW; Kim YM; Moon KH; Lee SH; Park S Investig Clin Urol; 2021 Jul; 62(4):485-495. PubMed ID: 34190439 [TBL] [Abstract][Full Text] [Related]
9. NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells. Gordon CA; Gulzar ZG; Brooks JD Prostate; 2015 Apr; 75(5):517-26. PubMed ID: 25585568 [TBL] [Abstract][Full Text] [Related]
10. The STAT3 inhibitor galiellalactone inhibits the generation of MDSC-like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors. Hellsten R; Lilljebjörn L; Johansson M; Leandersson K; Bjartell A Prostate; 2019 Oct; 79(14):1611-1621. PubMed ID: 31348843 [TBL] [Abstract][Full Text] [Related]
11. Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1. Lin HP; Lin CY; Huo C; Hsiao PH; Su LC; Jiang SS; Chan TM; Chang CH; Chen LT; Kung HJ; Wang HD; Chuu CP Oncotarget; 2015 Mar; 6(9):6684-707. PubMed ID: 25788262 [TBL] [Abstract][Full Text] [Related]
12. SD-208, a novel protein kinase D inhibitor, blocks prostate cancer cell proliferation and tumor growth in vivo by inducing G2/M cell cycle arrest. Tandon M; Salamoun JM; Carder EJ; Farber E; Xu S; Deng F; Tang H; Wipf P; Wang QJ PLoS One; 2015; 10(3):e0119346. PubMed ID: 25747583 [TBL] [Abstract][Full Text] [Related]
13. Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen-independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis. Zhang B; Lai Y; Li Y; Shu N; Wang Z; Wang Y; Li Y; Chen Z Eur J Pharmacol; 2018 Feb; 821():57-67. PubMed ID: 29277717 [TBL] [Abstract][Full Text] [Related]
14. GL-V9, a newly synthetic flavonoid derivative, induces mitochondrial-mediated apoptosis and G2/M cell cycle arrest in human hepatocellular carcinoma HepG2 cells. Li L; Lu N; Dai Q; Wei L; Zhao Q; Li Z; He Q; Dai Y; Guo Q Eur J Pharmacol; 2011 Nov; 670(1):13-21. PubMed ID: 21944925 [TBL] [Abstract][Full Text] [Related]
16. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer. Martin SK; Kyprianou N Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899 [TBL] [Abstract][Full Text] [Related]
17. The fungal metabolite galiellalactone interferes with the nuclear import of NF-κB and inhibits HIV-1 replication. Pérez M; Soler-Torronteras R; Collado JA; Limones CG; Hellsten R; Johansson M; Sterner O; Bjartell A; Calzado MA; Muñoz E Chem Biol Interact; 2014 May; 214():69-76. PubMed ID: 24631022 [TBL] [Abstract][Full Text] [Related]
18. Piperine blocks voltage gated K George K; Thomas NS; Malathi R Arch Biochem Biophys; 2019 May; 667():36-48. PubMed ID: 31047869 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of androgen receptors by NaAsO Kim Y; Park SE; Moon JW; Kim BM; Kim HG; Jeong IG; Yoo S; Ahn JB; You D; Pak JH; Kim S; Hwang JJ; Kim CS Prostate; 2017 Jul; 77(10):1128-1136. PubMed ID: 28556958 [TBL] [Abstract][Full Text] [Related]
20. NUSAP1 promotes invasion and metastasis of prostate cancer. Gordon CA; Gong X; Ganesh D; Brooks JD Oncotarget; 2017 May; 8(18):29935-29950. PubMed ID: 28404898 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]